Dr. John R. Mcguire, MD
Physical Medicine & Rehabilitation (PM&R) (Physical Medicine & Rehabilitation Physician)
9200 W Wisconsin Ave, Physical Medicine And Rehabilitation
Milwaukee, WI 53226
Who else practices at this address →
Milwaukee County includes primary care (32% of residents) and mental health (34% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Minnesota Medical School (1987)
- Years since graduation
- 39
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 217
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1987Medical school: University of Minnesota Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Physical Medicine & Rehabilitation Physician primary
WI license 39323
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Physical Medicine & Rehabilitation (PM&R) per capita by county →
Where they work
Hospitals
- Froedtert Memorial Lutheran Hospital Milwaukee, WI
Medical groups
- The Medical College of Wisconsin Inc (2,115 clinicians)
- Froedtert Andthe Medical College of Wisconsin Community Physicians Inc (1,285 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 217
- Services billed
- 41,112
- Patients’ average age
- 64
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 20,000 | 21 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 339 | 146 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 221 | 72 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 154 | 72 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 143 | 62 |
| Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | 95 | 38 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, each additional extremity | 72 | 30 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 69 | 32 |
| Injection of chemical for paralysis of nerve muscles on side of face | 49 | 17 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 18 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Baclofen Other prescribers in Milwaukee, WI | 226 |
| Gabapentin Other prescribers in Milwaukee, WI | 61 |
| Tizanidine Hcl Other prescribers in Milwaukee, WI | 61 |
| Diazepam Other prescribers in Milwaukee, WI | 25 |
| Cyclobenzaprine Hcl Other prescribers in Milwaukee, WI | 24 |
| Dantrolene Sodium | 24 |
| Tramadol Hcl Other prescribers in Milwaukee, WI | 16 |
| Clonazepam Other prescribers in Milwaukee, WI | 15 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Milwaukee, WI | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 26 payments worth $14,333 in total to this clinician.
| Merz Pharmaceuticals, LLC | $7,984 |
|---|---|
| Ipsen Biopharmaceuticals, Inc | $5,874 |
| Pacira Pharmaceuticals Incorporated | $364 |
| AbbVie Inc. | $111 |
| Compensation for services other than consulting (speaking, faculty) | $13,185 |
|---|---|
| Food and Beverage | $1,148 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $5,625 |
| Merz Pharmaceuticals, LLC Jul 8, 2025 | Compensation for services other than consulting (speaking, faculty) Xeomin · Musculoskeletal | $2,700 |
| Merz Pharmaceuticals, LLC Aug 26, 2025 | Compensation for services other than consulting (speaking, faculty) Xeomin · Musculoskeletal | $2,700 |
| Merz Pharmaceuticals, LLC Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) Xeomin · Musculoskeletal | $1,080 |
| Merz Pharmaceuticals, LLC Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) Xeomin · Musculoskeletal | $540 |
| Merz Pharmaceuticals, LLC Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) Xeomin · Musculoskeletal | $540 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $56,319 in research payments for these studies, mostly to the institutions running them.
- Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 in the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury in Adu…
Merz Pharmaceuticals, LLC - A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development
Ipsen Pharma Sas · Active, not recruiting · NCT06055725
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.